Methylene blue associated with maghemite nanoparticles has antitumor activity in breast and ovarian carcinoma cell lines

ConclusionsTreatment with MAGCIT –MB induces the death of cancer cells but not normal cells. These results highlight the importance of the maghemite core for drug delivery and for increasing methylene blue activity, aiming at the treatment of breast and ovarian cancer.Graphic Abstract
Source: Cancer Nanotechnology - Category: Cancer & Oncology Source Type: research